Immune Tolerance in Cancer and Autoimmune Disease

Abcam, Inc.
Last Modified: February 13, 2009

Share article

Conference Dates: May 06 - 09, 2009
Conference Location: Antigua

Sponsoring Group: Abcam, Inc.

Conference Web Page URL:

Conference Objectives: Immune Tolerance in Cancer and Autoimmune Disease: how to break it, and how to (re-)make it.

Conference Agenda: Immune Tolerance in Cancer and Autoimmune Disease: how to break it, and how to (re-)make it.

Registration Information: The fee is fully inclusive of: conference registration and materials, including book of abstracts accommodation for the nights of May 6, 7 and 8 all meals, snacks and unlimited drinks transfers to/from the hotel in Antigua non-motorized water sports Early Bird (by Mar 6, 2009) Standard (by Mar 27, 2009) Single $995 $1195 Twin/Double $895 $995 Student (twin)* $795 $895 Partners ** $450 $500

Continuing Education: Yes

New Cervical Cancer Vaccine Targets HPV-Infected Women

Oct 11, 2012 - A new candidate vaccine designed to prevent cervical dysplasia and cancer in women already infected with human papillomavirus serotypes 16 and 18 is well tolerated and induces a robust immune response, according to a phase 1 study published in the Oct. 10 issue of Science Translational Medicine.

OncoLink Treatment Binder

Select the side effects and forms for your patient's treatment binder

Learn More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More